title: ESGAB breakpoint determination: clarithromycin.
authors.forename: I
authors.initials: I
authors.lastname: Phillips
authors.forename: J
authors.initials: J
authors.lastname: Acar
authors.forename: F
authors.initials: F
authors.lastname: Baquero
authors.forename: T
authors.initials: T
authors.lastname: Bergan
authors.forename: A
authors.initials: A
authors.lastname: Forsgren
authors.forename: B
authors.initials: B
authors.lastname: Wiedemann
mesh_terms: D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D017291:Clarithromycin; D004917:Erythromycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D009177:Mycoplasma pneumoniae / Q000187:drug effects
chemical_list: D004917:Erythromycin; D017291:Clarithromycin